COVID-19 is a rapidly evolving situation. When working in different community settings, follow CDC guidance External Web Site Icon to help prevent the spread of COVID-19. Visit www.cdc.gov/coronavirus External Web Site Icon for the latest public health information.

Targeted Vaccinations: Client or Family Incentives - Inactive

Tabs

What the CPSTF Found

About The Systematic Review

One study qualified for the systematic review.

These results were based on a systematic review of all available studies, conducted on behalf of the Task Force by a team of specialists in systematic review methods, and in research, practice, and policy related to vaccinations to prevent diseases.

Context

There is no information for this section.

Summary of Results

This study evaluated the implementation of a $10 incentive to increase hepatitis B vaccination coverage among recruited injection drug users. The incentive increased vaccination by 35 percentage points. Although this is a relatively large increase, this single study alone did not provide enough evidence for the Task Force to determine whether or not client incentives by themselves are effective in increasing vaccination coverage.

Summary of Economic Evidence

An economic review of this intervention was not conducted because the Task Force did not have enough information to determine if the intervention works.

Applicability

Applicability of this intervention across different settings and populations was not assessed because the Task Force did not have enough information to determine if the intervention works.

Evidence Gaps

No content is available for this section.

Study Characteristics

No content is available for this section.

Publications